Exane Derivatives’s Itron ITRI Stock Holding History

Exane Derivatives’s Portfolio ITRI Stock Details ITRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-401	Closed	-$21.1K	–	866
2022 Q1	$21.1K	Sell	401 -406	-50%	-$22.7K	0.01%	660
2021 Q4	$55.3K	Sell	807 -3,419	-81%	-$241K	0.01%	483
2021 Q3	$320K	Buy	4,226 +2,855	+208%	+$245K	0.08%	271
2021 Q2	$133K	Sell	1,371 -2,951	-68%	-$274K	0.03%	509
2021 Q1	$383K	Buy	4,322 +538	+14%	+$53.2K	0.11%	185
2020 Q4	$363K	Buy	3,784 +1,961	+108%	+$151K	0.11%	223
2020 Q3	$111K	Buy	+1,823	New	+$116K	0.03%	290

Other funds holding ITRI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Exane Derivatives's ITRI Position: Q2 2022 in Review

Exane Derivatives sold out of Itron (ITRI) in Q2 2022, closing a stake of 401 shares — an estimated $21.1K sold.

Exane Derivatives first reported a position in ITRI in Q3 2020 and held it in 7 quarters. The position peaked at $383K in Q1 2021. 250 funds tracked by Wall St. Rank hold ITRI as of Q2 2022.

Exane Derivatives reported no remaining Itron position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 401 Itron shares in Q2 2022, an estimated $21.1K.
Exane Derivatives first reported a position in Itron in Q3 2020 and held it in 7 quarters.
Exane Derivatives's Itron position peaked at $383K in Q1 2021.
250 funds tracked by Wall St. Rank held Itron as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.